Bruker

Founded in 1960 by Günther Laukien and Emil Bruker in Germany, Bruker Corporation is a publicly traded company headquartered in Billerica, Massachusetts. The company's core mission is to advance scientific research and improve quality control through innovative life science systems and analytical tools. Bruker specializes in spectrometry and X-ray technology platforms, offering products for structural and elemental analysis, pathogen identification, and substance detection. Their market focus spans materials research, life sciences, and quality control industries.

Notable figures include Frank Laukien, who serves as chairman, president, and CEO. Bruker is listed on the Nasdaq under the ticker BRKR and is a component of the S&P 400. The company reported a revenue of $2.96 billion in 2023 and employs over 9,700 people. Bruker's significant achievements include pioneering advancements in X-ray diffraction and fluorescence technologies, contributing substantially to scientific research and industrial applications globally.